2 Growth Stocks to Buy in November Without Any Hesitation
Vertex Pharmaceuticals and Regeneron Pharmaceuticals are recommended as strong growth stocks for November. Both biotech companies started 2026 slowly but have rebounded with above-average returns. Vertex is poised for approval of povetacicept for kidney disease and has a pipeline potentially worth $10 billion in annual sales. Regeneron is driven by blockbuster Dupixent sales (up 35% YoY) and is managing Eylea's decline with a newer HD formulation.

